[Induction-intubation sequence in neuroanesthesia. Usefulness of vecuronium in fractionated doses].
M A Martínez de Gereñu Alonso, Castells Armenter Mv, Carlos Ocasio Lopez, Ll. García
Abstract
M A Martínez de Gereñu Alonso, Castells Armenter Mv, Carlos Ocasio Lopez, Ll. García
Abstract
Muscular relaxant vecuronium bromide (Norcuron R, Organon Teknika Española, S.A.) was administered to 20 patients undergoing intracranial surgery with general anesthesia at a dose of 0.01 mg/kg weight followed by 0.1 mg/kg (intubation dose) four minutes later. Two minutes after the second dose and under careful manual mechanical ventilation with O2 100%, a laryngoscopy was performed to evaluate the conditions for intubation. Mean arterial pressure, heart rate, PaO2, and PaCO2 were measured at baseline and immediately before laryngoscopy. Neuromuscular function was monitored observing the response to a train of four stimuli applied on the cubital nerve. During the operation a continuous infusion of vecuronium at a rate of 1 microgram/kg/min was maintained. Conditions for intubation were excellent in 18 patients and good in two cases. Mean heart rate and PaCO2 did not show significant variations. In contrast, during prelaryngoscopy mean arterial pressure decreased and PaO2 increased with respect to the baseline values. During surgery all patients showed a good clinical relaxation. Thus, we believe that vecuronium is a good muscular relaxant agent, safe, and effective to be used in neurosurgery.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Muscular relaxant vecuronium bromide (Norcuron R, Organon Teknika Española, S.A.) was administered to 20 patients undergoing intracranial surgery with general anesthesia at a dose of 0.01 mg/kg weight followed by 0.1 mg/kg (intubation dose) four minutes later. Two minutes after the second dose and under careful manual mechanical ventilation with O2 100%, a laryngoscopy was performed to evaluate the conditions for intubation. Mean arterial pressure, heart rate, PaO2, and PaCO2 were measured at baseline and immediately before laryngoscopy. Neuromuscular function was monitored observing the response to a train of four stimuli applied on the cubital nerve. During the operation a continuous infusion of vecuronium at a rate of 1 microgram/kg/min was maintained. Conditions for intubation were excellent in 18 patients and good in two cases. Mean heart rate and PaCO2 did not show significant variations. In contrast, during prelaryngoscopy mean arterial pressure decreased and PaO2 increased with respect to the baseline values. During surgery all patients showed a good clinical relaxation. Thus, we believe that vecuronium is a good muscular relaxant agent, safe, and effective to be used in neurosurgery.
Key concepts: Anesthesia, Vecuronium bromide, Medicine, Intubation, Muscle relaxant, Laryngoscopy, Muscle relaxation, Heart rate